Innovation Excellence is a unique application of lean kaizen methodologies and personal coaching. It frees up capacity for innovative research, fosters ownership and significantly enhances the output of your research and innovation teams.
Innovation Excellence is a unique application of lean kaizen methodologies and personal coaching. It frees up capacity for innovative research, fosters ownership and significantly enhances the output of your research and innovation teams. It has the goal to improve current work processes in research and development but also life cycle management to increase efficiency. Together with ICH Q8 elements like Quality by Design, Innovation Excellence has to be seen as an overarching paradigm and an interdisciplinary approach across the product development lifecycle. It also systematically emphasises enhanced product throughout the product lifecycle.
Applying a management style that focuses on the process of learning, the art of continuous and scientific research can create a physical as well as a social environment where innovation can flourish.
The Workshop Innovation Excellence , which is also supported by an FDA speaker, will apply continuous improvement tools to help you gain the right knowledge. It will therefore give you a fresh view on how to make your research and development more efficient, faster and customer focused. For that purpose the training is filled with real life examples and exercises on how to:
To provide you the maximum benefit the Workshop is a mix of theoretic foundation and exercises.
For further information please see www.gmp-compliance.org/innovation.
Contact:
European Compliance Academy (ECA)
www.gmp-compliance.orginfo@gmp-compliance.org
Event date: October 30, 2012 - October 31, 2012, Berlin, Germany
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.